MGC Pharmaceuticals Correlations
| MGCLFDelisted Stock | USD 0.21 0.00 0.00% |
The current 90-days correlation between MGC Pharmaceuticals and Aequus Pharmaceuticals is 0.13 (i.e., Average diversification). The correlation of MGC Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
MGC Pharmaceuticals Correlation With Market
Very good diversification
The correlation between MGC Pharmaceuticals and DJI is -0.21 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MGC Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
MGC |
The ability to find closely correlated positions to MGC Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MGC Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MGC Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MGC Pharmaceuticals to buy it.
Moving together with MGC OTC Stock
| 0.88 | MKKGY | Merck KGaA ADR | PairCorr |
| 0.85 | MKGAF | MERCK Kommanditgesells | PairCorr |
| 0.64 | TKPHF | Takeda Pharmaceutical | PairCorr |
| 0.72 | HLN | Haleon plc | PairCorr |
| 0.78 | TAK | Takeda Pharmaceutical | PairCorr |
| 0.67 | TEVA | Teva Pharmaceutical | PairCorr |
| 0.62 | HLNCF | Haleon plc | PairCorr |
| 0.73 | TEVA | Teva Pharma Industries | PairCorr |
| 0.69 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.83 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.86 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.79 | PBCRY | Bank Central Asia | PairCorr |
| 0.68 | PBCRF | PT Bank Central | PairCorr |
| 0.82 | BKRKY | Bank Rakyat | PairCorr |
| 0.77 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.8 | KO | Coca Cola Fiscal Year End 11th of February 2025 | PairCorr |
| 0.72 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.9 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.87 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
Moving against MGC OTC Stock
| 0.5 | PTAIF | PT Astra International | PairCorr |
| 0.4 | SSNLF | Samsung Electronics | PairCorr |
| 0.87 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.86 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.85 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.82 | WMT | Walmart | PairCorr |
| 0.79 | CSCO | Cisco Systems | PairCorr |
| 0.63 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.62 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.4 | CAT | Caterpillar Sell-off Trend | PairCorr |
| 0.32 | PG | Procter Gamble | PairCorr |
| 0.31 | HPQ | HP Inc | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between MGC OTC Stock performing well and MGC Pharmaceuticals OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MGC Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CBDNF | 3.63 | (0.25) | 0.00 | 0.64 | 0.00 | 14.75 | 47.67 | |||
| CBDY | 8.80 | 0.40 | 0.02 | 0.46 | 10.32 | 14.29 | 76.03 | |||
| AQSZF | 3.83 | (0.76) | 0.00 | 1.22 | 0.00 | 7.84 | 54.76 | |||
| FLHLF | 11.82 | 0.29 | 0.03 | 0.17 | 13.83 | 31.04 | 91.17 | |||
| SKYI | 21.35 | 6.08 | 0.11 | (1.37) | 19.00 | 56.25 | 250.98 | |||
| LVTTF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SFWJ | 15.25 | 4.02 | 0.16 | (1.02) | 14.01 | 48.08 | 185.19 | |||
| BCBCF | 20.41 | 9.13 | 0.39 | 7.24 | 9.22 | 26.81 | 425.33 | |||
| AXRX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ANTCF | 29.49 | 9.42 | 0.15 | 1.53 | 20.40 | 84.21 | 451.80 |
MGC Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MGC Pharmaceuticals otc stock to make a market-neutral strategy. Peer analysis of MGC Pharmaceuticals could also be used in its relative valuation, which is a method of valuing MGC Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
MGC Pharmaceuticals Corporate Management
Elected by the shareholders, the MGC Pharmaceuticals' board of directors comprises two types of representatives: MGC Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MGC. The board's role is to monitor MGC Pharmaceuticals' management team and ensure that shareholders' interests are well served. MGC Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MGC Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yifat Steuer | Deputy COO | Profile | |
| Robert Clements | Chief Officer | Profile | |
| AngelaMarie Graham | Group Officer | Profile | |
| Yair Tal | Chief Officer | Profile | |
| Sasha Friedman | Deputy CEO | Profile | |
| Sabina Suljakovic | Head Department | Profile |
Still Interested in MGC Pharmaceuticals?
Investing in delisted otcs can be risky, as the otc stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.